GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646 participant visits, including both ...

With a singular focus on healthcare, Kalorama continues to shape informed decision-making across the industry through comprehensive, evidence-based analysis.

A free webinar has encouraged medical device innovators to learn more about new Post-Market Surveillance (PMS) legislation ...

The company plans to bring to market in the coming years a series of microarray-based tests for autoimmune diseases and allergies, among other tests.

Learn how in vitro diagnostic (IVD) devices can comply with IVDR and Indian MDR standards, ensuring regulatory alignment, ...

On 6 June 2025, the European Commission launched a targeted stakeholder consultation on the classification and regulation of ...

The assay claims to deliver an ultra-sensitive DNA sequencing method to detect minimal residual leukaemia cells.

3. AI Life Cycle Language Strategy for MDR and IVDR: Innovative guidance on leveraging Artificial Intelligence (AI) and Large Language Models (LLMs) to optimize language outcomes through a risk-based ...

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is attending and presenting ...